Initiation of long-acting cabotegravir plus rilpivirine as direct-to-injection or with an oral lead-in in adults with HIV-1 infection: week 124 results of the open-label phase 3 FLAIR study
| Autor: | Orkin, Chloe *, Bernal Morell, Enrique, Tan, Darrell H S, Katner, Harold, Stellbrink, Hans-Jürgen, Belonosova, Elena, DeMoor, Rebecca, Griffith, Sandy, Thiagarajah, Shanker, Van Solingen-Ristea, Rodica, Ford, Susan L, Crauwels, Herta, Patel, Parul, Cutrell, Amy, Smith, Kimberly Y, Vandermeulen, Kati, Birmingham, Eileen, St Clair, Marty, Spreen, William R, D'Amico, Ronald |
|---|---|
| Zdroj: | In The Lancet HIV November 2021 8(11):e668-e678 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|